Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sandra Martha Gomes Dias has a total of 253 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Differential Cytotoxicity of PVP-Copper Nanoparticles in Breast Cancer Cell Lines: Insights from Basal Transcriptomic Profiles

    by Anelise G. Silva, Izaque J. O. Silva, Pedro P. Tanaka, Matheus Z. Monteiro, Sérgio Servilha Oliveira Filho, Jefferson M. Souza, Valeria S. Marangoni, Sandra M. G. Dias, Cyro. Z. V. Negrão

    Breast cancer is a heterogeneous disease comprising molecular subtypes with distinct therapeutic vulnerabilities. Among emerging therapeutic strategies, copper-based nanoparticles have shown anticancer activity. However, whether these responses differ across breast cancer subtypes and which molecular programs underlie copper sensitivity remain poorly understood. We investigated subtype-specific responses to Polyvinylpyrrolidone-assisted copper nanoparticles (CuNP-PVP) in breast cancer cell lines and the molecular programs underlying copper adaptation. CuNP-PVP were synthesized and evaluated in luminal (MCF-7), HER2-positive (SKBR3), and triple-negative (MDA-MB-231) breast cancer cell lines, with transcriptomic analyses integrated with CCLE and TCGA-BRCA datasets. UV-Vis spectroscopy revealed a plasmon resonance band at 591 nm, while TEM showed spherical nanoparticles with an average diameter of 76.1 ± 21.0 nm. DLS indicated a larger hydrodynamic diameter, consistent with PVP coating; ζ-potential measurements showed a surface charge of −13 mV, and XPS confirmed mixed reduced and Cu(I)/Cu(II) oxidation states. Exposure to 100 μg/mL CuNP-PVP induced subtype-dependent effects on cell viability, with MCF-7 showing greater sensitivity, whereas MDA-MB-231 and SKBR3 were less affected. Baseline transcriptomic analyses revealed enrichment of oxidative stress, metabolic adaptation, and lysosomal programs in less sensitive cells, whereas MCF-7 showed higher expression of lipoylation-related genes. These features supported the development of a Potential Biological Copper-Response Index (PBCRI), which captured subtype-associated transcriptional patterns across independent cell lines and patient tumors, with luminal models showing lower scores and basal/TNBC models showing higher scores. Together, these findings identify candidate transcriptional programs associated with subtype-specific responses to CuNP and provide a framework for investigating potential molecular determinants of copper sensitivity. Highlights: PVP-assisted copper nanoparticles showed mixed metallic/oxidized Cu phases. CuNP-PVP induced cell-dependent cytotoxicity in breast cancer cells. MCF-7 cells were more sensitive to CuNP-PVP than TNBC and HER2+ cells. Baseline profiles differed in lipoylation, antioxidant, and lysosomal programs. PBCRI captured subtype-associated copper-response transcriptional patterns.

  • Open Access

    Beyond Capture Efficiency: A Multidimensional Framework for Benchmarking Circulating Tumor Cell Isolation Technologies

    by Cyro von Zuben de Valega Negrao, Haley Hendrick, Farah Ammar, Remi V. Klotz, Sandra Dias, Min Yu

    Metastasis remains the major cause of cancer-related mortality, and circulating tumor cells (CTCs) are both candidate liquid-biopsy biomarkers and plausible intermediates of metastatic dissemination. Because CTCs are extremely rare in peripheral blood, platform comparisons have often focused solely on recovery. That focus is insufficient for applications that depend on the quality of the recovered material, including single-cell profiling, short-term culture, and functional testing. Here, we compared four CTC isolation approaches: TellDx CTC System, Genesis System, RosetteSep™, and flow cytometry, using spike-in experiments in human blood. Capture efficiency was evaluated across all four platforms; purity was assessed for TellDx, Genesis, and RosetteSep™; and post-isolation GFP signal persistence in culture was assessed for TellDx and Genesis as an exploratory proxy for short-term post-isolation preservation. Under the conditions tested, TellDx showed the highest recovery (88.1% ± 3.7%), followed by Genesis (40.6% ± 12.1%), RosetteSep™ (36.5% ± 9.0%), and flow cytometry (7.6% ± 4.5%). TellDx also showed the highest purity score (3.76), whereas Genesis (2.25) and RosetteSep™ (2.09) did not differ substantially. In the short-term culture assay, TellDx-derived samples retained a higher normalized GFP signal than Genesis-derived samples at 48 h and 72 h. To synthesize these readouts, we propose the Recovery Performance Index (RPI), a composite score integrating recovery, purity, and post-isolation signal persistence. Within this experimental framework, TellDx achieved the highest RPI. These data support two conclusions. First, platform benchmarking for CTC workflows benefits from multidimensional evaluation rather than recovery alone. Second, under this spike-in model and within the specific workflows used here, TellDx performed best among the platforms tested. The principal contribution of this study is therefore the establishment of a practical benchmarking framework that can be expanded in future work using clinical samples, multiple CTC phenotypes, and orthogonal viability assays.

  • Open Access

    Glutamine metabolic enzymes: to filament or not to filament?

    by Raquel A.C. Machado, Ivan Rosa e Silva, Thaís Fontes-Milz, Yuan Chang-Halabi, Jhon A. Vargas, Andre L.B. Ambrosio, Sandra M.G. Dias

    The self-assembly of metabolic enzymes into filaments and other supramolecular structures is well-documented in bacteria and yeast but remains largely unexplored in mammalian cells. Enzyme filamentation is thought to play a crucial role in regulating metabolic networks by modulating enzymatic activity in response to cellular demands. Studies in yeast suggest that filament-forming enzymes are often positioned at key junctions of metabolic pathways, enabling dynamic activation or inactivation during growth or stress and directing metabolic flux accordingly. While this mechanism appears to be broadly conserved across species, the structural and functional characterization of human homologs of filamentous enzymes remains limited. In the present review, we focus on the glutamine metabolic pathway, highlighting enzymes known to form large self-assemblies in cells and examining the few cases where structural insights are available. Finally, we discuss the broader implications of metabolic enzyme filamentation in mammalian cells, underscoring its potential as an emerging area of research.

  • Open Access

    Violacein-Loaded Outer Membrane Vesicles from Salmonella enterica Exhibit Potent Anti-Melanoma Activity in Vitro and in Vivo

    by Genesy Pérez Jorge, Marco Gontijo, Marina Flóro e Silva, Raquel Bester Liszbinski, Renata Spagolla Napoleão Tavares, Cyro von Zuben de Valega Negrão, Carlismari Oliveira Grundmann, Isabella Carolina Rodrigues dos Santos Goes, Lilian de Oliveira Coser, Elizabeth Bilsland, et al.

    Violacein exhibits antitumor activity, indicating potential for future clinical application. However, an efficient delivery system is required for the clinical use of this hydrophobic compound. Effective delivery systems can enhance the solubility and bioavailability of hydrophobic compounds like violacein, facilitating its clinical application for antitumor therapy. Recent studies have demonstrated that outer membrane vesicles (OMVs) can serve as nanocarriers. This article constitutes the first report to present both in vivo and in vitro investigations of OMVs derived from a hypervesiculating mutant of Salmonella enterica Typhimurium as a delivery vehicle for violacein. In this study, S. enterica Typhimurium ΔtolRA (with a hypervesiculated phenotype) was transformed with a plasmid encoding the violacein biosynthesis operon. OMVs and violacein-loaded OMVs were isolated, characterized, and used in the treatment of murine melanoma. We assessed the cytotoxic effect of these violacein-loaded OMVs in both two-dimensional (2D) and three-dimensional (3D) cell cultures. Violacein-loaded OMVs reduced melanoma cell viability (IC50: 9.30 × 108 vesicles/mL) and delivered violacein in melanoma cells. Additionally, tumor regression was associated with treating tumor-bearing mice with violacein-loaded OMVs or nonviolacein-loaded OMVs (5 × 109 vesicles/mouse). The antitumor response was linked to the accumulation of M1-type macrophages in the tumor microenvironment and the overexpression of mRNA for antitumor mediators Inducible Nitric Oxide Synthase, Tumor Necrosis Factor-alpha, and Interleukin-6 (iNOS, TNF-α, and IL-6). Our results suggest that OMVs can act as nanocarriers for highly hydrophobic agents and induce antitumor responses to eliminate tumors.


  • Open Access

    HuR controls glutaminase RNA metabolism

    by Douglas Adamoski, Larissa M. dos Reis, Ana Carolina Paschoalini Mafra, Felipe Corrêa-Da-Silva, Pedro Manoel Mendes de Moraes-Vieira, Ioana Berindan-Neagoe, George A. Calin, Sandra Martha Gomes Dias

    Glutaminase (GLS) is directly related to cell growth and tumor progression, making it a target for cancer treatment. The RNA-binding protein HuR (encoded by the ELAVL1 gene) influences mRNA stability and alternative splicing. Overexpression of ELAVL1 is common in several cancers, including breast cancer. Here we show that HuR regulates GLS mRNA alternative splicing and isoform translation/stability in breast cancer. Elevated ELAVL1 expression correlates with high levels of the glutaminase isoforms C (GAC) and kidney-type (KGA), which are associated with poor patient prognosis. Knocking down ELAVL1 reduces KGA and increases GAC levels, enhances glutamine anaplerosis into the TCA cycle, and drives cells towards glutamine dependence. Furthermore, we show that combining chemical inhibition of GLS with ELAVL1 silencing synergistically decreases breast cancer cell growth and invasion. These findings suggest that dual inhibition of GLS and HuR offers a therapeutic strategy for breast cancer treatment.


  • Open Access

    Architecture and regulation of filamentous human cystathionine beta-synthase

    by Thomas J. McCorvie, Douglas Adamoski, Raquel A. C. Machado, Jiazhi Tang, Henry J. Bailey, Douglas S. M. Ferreira, Claire Strain-Damerell, Arnaud Baslé, Andre L. B. Ambrosio, Sandra M. G. Dias, et al.

    Cystathionine beta-synthase (CBS) is an essential metabolic enzyme across all domains of life for the production of glutathione, cysteine, and hydrogen sulfide. Appended to the conserved catalytic domain of human CBS is a regulatory domain that modulates activity by S-adenosyl-L-methionine (SAM) and promotes oligomerisation. Here we show using cryo-electron microscopy that full-length human CBS in the basal and SAM-bound activated states polymerises as filaments mediated by a conserved regulatory domain loop. In the basal state, CBS regulatory domains sterically block the catalytic domain active site, resulting in a low-activity filament with three CBS dimers per turn. This steric block is removed when in the activated state, one SAM molecule binds to the regulatory domain, forming a high-activity filament with two CBS dimers per turn. These large conformational changes result in a central filament of SAM-stabilised regulatory domains at the core, decorated with highly flexible catalytic domains. Polymerisation stabilises CBS and reduces thermal denaturation. In PC-3 cells, we observed nutrient-responsive CBS filamentation that disassembles when methionine is depleted and reversed in the presence of SAM. Together our findings extend our understanding of CBS enzyme regulation, and open new avenues for investigating the pathogenic mechanism and therapeutic opportunities for CBS-associated disorders.


  • HER2 Aptamer-Conjugated Iron Oxide Nanoparticles with PDMAEMA-b-PMPC Coating for Breast Cancer Cell Identification

    by Cyro von Zuben de Valega Negrão, Natália Np Cerize, Amauri da Silva Justo-Junior, Raquel Bester Liszbinski, Giovanna Pastore Meneguetti, Larissa Araujo, Silvana A Rocco, Kaliandra de Almeida Gonçalves, Daniel R Cornejo, Patrícia Leo, et al.

    Aim: To synthesize HER2 aptamer-conjugated iron oxide nanoparticles with a coating of poly(2-(dimethylamino) ethyl methacrylate)–poly(2-methacryloyloxyethylphosphorylcholine) block copolymer (IONPP...


  • Molecular mechanism of glutaminase activation through filamentation and the role of filaments in mitophagy protection

    by Douglas Adamoski, Marilia Meira Dias, Jose Edwin Neciosup Quesñay, Zhengyi Yang, Ievgeniia Zagoriy, Anna M. Steyer, Camila Tanimoto Rodrigues, Alliny Cristiny da Silva Bastos, Bianca Novaes da Silva, Renna Karoline Eloi Costa, et al.

    Glutaminase (GLS), which deaminates glutamine to form glutamate, is a mitochondrial tetrameric protein complex. Although inorganic phosphate (Pi) is known to promote GLS filamentation and activation, the molecular basis of this mechanism is unknown. Here we aimed to determine the molecular mechanism of Pi-induced mouse GLS filamentation and its impact on mitochondrial physiology. Single-particle cryogenic electron microscopy revealed an allosteric mechanism in which Pi binding at the tetramer interface and the activation loop is coupled to direct nucleophile activation at the active site. The active conformation is prone to enzyme filamentation. Notably, human GLS filaments form inside tubulated mitochondria following glutamine withdrawal, as shown by in situ cryo-electron tomography of cells thinned by cryo-focused ion beam milling. Mitochondria with GLS filaments exhibit increased protection from mitophagy. We reveal roles of filamentous GLS in mitochondrial morphology and recycling.


  • Open Access

    Iron Oxide Nanoparticles Coated with Biodegradable Block-Copolymer PDMAEMA-b-PMPC and Functionalized with Aptamer for HER2 Breast Cancer Cell Identification

    by Cyro von Zuben de Valega Negrão, Natália Neto Pereira Cerize, Amauri da Silva Justo-Junior, Raquel Bester Liszbinski, Giovanna Pastore Meneguetti, Larissa Araujo, Silvana Aparecida Rocco, Kaliandra de Almeida Gonçalves, Daniel Reinaldo Cornejo, Patrícia Leo, et al.

    Hybrid nanoparticles have shown promise in biomedical applications; however, their seamless integration into clinical settings remains challenging. Here, we introduce a novel metal oxide polymer hybrid nanoparticle (NP) with a high affinity for nucleic acids. Iron oxide nanoparticles (IONP) were initially synthesized via the co-precipitation method and subjected to comprehensive characterization. Subsequently, block copolymers were synthesized using the Reversible Addition−Fragmentation Chain Transfer (RAFT) technique, employing the zwitterionic PMPC (Poly (2 Methacryloyloxyethyl Phosphorylcholine)) and the cationic PDMAEMA (Poly(2 (Dimethylamino) Ethyl Methacrylate)) with varying degrees of polymerization. In vitro cytotoxicity studies demonstrated the biocompatibility of the synthesized nanoparticles, with no observed toxicity up to a concentration of 150 µg/mL. The cationic polymer PDMAEMA facilitated the facile coating of IONP, forming the IONPP complex, consisting of a 13.27 metal core and a 3.1 nm block-copolymer coating. Subsequently, the IONPP complex was functionalized with a DNA aptamer specifically targeting the human epidermal growth factor receptor 2 (HER2) in breast cancer, forming IONPPP. The block-copolymer exhibited an EC 50 of 7.07 µg/mL and demonstrated enhanced recognition efficiency in HER2-amplified SKBR3 cells. Our study presents a comprehensive IONPPP characterization capable of binding short DNA sequences and targeting proteins such as HER2. This newly developed nanoparticle holds significant potential for cancer cell identification and isolation, offering promising prospects in cancer research and clinical applications. 1. Statement of significance: Despite recent advancements in biomedical research, developing sensitive and specific tools for recognizing biological motifs, such as cell receptors and proteins in complex biological solutions, remains a challenge. Furthermore, current approaches often rely on complex biological derivatives like antibodies, lacking a cost-effective delivery strategy. Our study proposes creating and characterizing a novel hybrid metal oxide polymer nanoparticle named IONPPP, functionalized with a DNA aptamer designed to recognize HER2-positive cells. HER2 is a clinically actionable marker for gastric, gastroesophageal, and, particularly, breast cancers. This unique combination of a metal core with an external polymeric structure offers the potential for identification, isolation, and even theragnostic applications, benefiting from its low toxicity and high specificity. 2. Graphical